Michele is a seasoned healthcare executive with over 25 years of international experience spanning in-vitro diagnostics, digital health, life sciences and personalized medicine.
During his tenure at Roche Michele held senior leadership positions across corporate strategy, commercial and business development including serving as Global Head of Strategy and Business Development for Diagnostics. Under his leadership, the division pioneered the entry into digital health and executed more than 20 acquisitions and 500 licensing deals. Prior leadership positions held at Roche included multiple international roles where Michele served as in-country and regional general manager and built a track record of profitably growing businesses in emerging and mature markets. Moreover, he had an instrumental role in introducing patient selection through Companion Diagnostics (CDx) and establishing polymerase chain reaction (PCR) as a routine diagnostics methodology.
Michele is currently an Independent Strategic Advisor and Non-Executive Director to private and public healthcare companies.
Michele received his PhD in Molecular Biology from the University of Zürich and his MS degree in Biochemistry and Cell Biology from the Federal Institute of Technology (ETH) Zürich.